Patents by Inventor Stephan A. Hahn

Stephan A. Hahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor suppressor gene, DPC4
    Patent number: 5955292
    Abstract: Polynucleotide and polypeptide sequences encoding a novel tumor suppressor gene, DPC4, are provided. Also included is a method for detecting a cell proliferative disorder associated with DPC4. DPC4 is a marker which can be used diagnostically, prognostically and therapeutically over the course of disorders associated with DPC4.
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: September 21, 1999
    Assignee: The Johns Hopkins University School of Medicine
    Inventors: Scott E. Kern, Stephan A. Hahn
  • DPC4 polypeptide
    Patent number: 5814457
    Abstract: Polynucleotide and polypeptide sequences encoding a novel tumor suppressor gene, DPC4, are provided. Also included is a method for detecting a cell proliferative disorder associated with DPC4. DPC4 is a marker which can be used diagnostically, prognostically and therapeutically over the course of disorders associated with DPC4.
    Type: Grant
    Filed: August 20, 1997
    Date of Patent: September 29, 1998
    Assignee: The Johns Hopkins University School of Medicine
    Inventors: Scott E. Kern, Stephan A. Hahn
  • Tumor suppressor gene, DPC4
    Patent number: 5712097
    Abstract: Polynucleotide and polypeptide sequences encoding a novel tumor suppressor gene, DPC4, are provided. Also included is a method for detecting a cell proliferative disorder associated with DPC4. DPC4 is a marker which can be used diagnostically, prognostically and therapeutically over the course of disorders associated with DPC4.
    Type: Grant
    Filed: January 19, 1996
    Date of Patent: January 27, 1998
    Assignee: The Johns Hopkins University School of Medicine
    Inventors: Scott E. Kern, Stephan A. Hahn